Dr. Wilentz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Union Sq. E
Ste 2B
New York, NY 10003Phone+1 212-844-8830Fax+1 212-844-8831
Summary
- Board certified in Cardiovascular Disease and Interventional Cardiology, I have a hybrid practice combining consultation in cardiovascular health with cardiac and peripheral / carotid interventional treatment. This allows me to give the best possible care to my patients rather than just concentrating on procedures
Education & Training
- Emory University School of Medicine1985 - 1986
- Boston University Medical CenterFellowship, Cardiovascular Disease, 1982 - 1984
- Harvard CollegeFellowship, Internal Medicine, 1980 - 1982
- Peter Bent Brigham Hospital1979 - 1982
- Harvard CollegeFellowship, Internal Medicine, 1976 - 1980
- Peter Bent Brigham Hospital1976 - 1979
- New York University School of MedicineClass of 1976
- Columbia College, Columbia UniversityB.A, 1968 - 1972
Certifications & Licensure
- NY State Medical License 1986 - 2026
- NJ State Medical License 1999 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly
- NY Magazine/Castle Connolly Top Doctor Interventional Cardiology NY Magazine/Castle Connolly
- Fellow FAHA American Heart Association
- Join now to see all
Clinical Trials
- Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial Start of enrollment: 2014 Dec 09
Publications & Presentations
PubMed
- 15 citationsExercise-Related Atrioventricular Block: Influence of Myocardial IschemiaNeil L. Coplan, Monty C. Morales, Paul P. Romanello, James R. Wilentz, Jeffrey W. Moses
Chest. 1991-12-01 - 53 citationsSYNTAX Score and Long-Term Outcomes: The BARI-2D TrialFumiaki Ikeno, Maria M. Brooks, Kaori Nakagawa, Min Kyu Kim, Hideaki Kaneda
Journal of the American College of Cardiology. 2017-01-31 - 249 citationsEffect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyStephen G. Ellis, Gary S. Roubin, James R. Wilentz, John S. Douglas, Spencer B. King
American Heart Journal. 1989-04-01
Journal Articles
- Population health and sociodemographic variables as predictors of access to cardiac medicine and surgery in HaitiBansal E, Patel K, Lacossade S, Gue B, Acceme K, Robinson O, Kwan GF, Wilentz JR, BMC Global Health Research and Policy, 7/19/2023
- Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.Fuchs J Cannon CP for the TIMI 7 Investigators (Wilentz JR Principal Investigator, Circulation
- Mid-term results and patient perceptions of robotically-assisted coronary artery bypass grafting.DeRose JJ Jr, Balaram SK, Ro C, Swistel DG, Singh V, Wilentz JR, Todd GJ, Ashton RC Jr, Interactive Cardiovascular and Thoracic Surgery
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Bailout Stenting for Abrupt Closure During Coronary Angioplasty.Meckel CR Kjelsberg MA Ahmed WH Ganz P Piana RN Deutsch E Strony J Bittl JA Hirulog Angioplasty Study Investigators, Circulation
- Coronary Flow Reserve By Doppler Wire is NotEquivalent to Stenotic Flow Reserve.Lieberman SM, Undemir C, Shaknovich A, Wilentz JR, Friedman MS, Higgins J, CohenNT, McCrossen J, Moses JW, Circulation
- Clinical Evidence for Thrombin Rebound After Stopping Heparin but not Hirulog.Strony J Ahmed WH Meckel CR Maraganore J Adelman B Bittl JA, Hirulog Angioplasty Study Investigators, Circulation 1995 92: I-609
- Join now to see all
Professional Memberships
- Society for Cardiac Angiography and InterventionFellow
- Fellow
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: